Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

No Surprise: Genentech Urges Shareholders Not To Tender Shares

This article was originally published in The Pink Sheet Daily

Executive Summary

New details from Genentech’s SEC filing show the two companies have been at an impasse regarding the biotech’s valuation since fall 2008.
Advertisement

Related Content

The Genentech Sales Pitch: Higher Values R Us
The Genentech Sales Pitch: Higher Values R Us
How Sweet It Isn’t: Genentech Investors Want Higher Roche Bid
Roche/Genentech: A Case Study For Future Hostile Offers
Roche’s High-Stakes Gambit For Genentech
Genentech/Roche: The End Of An Era
Genentech/Roche: The End Of An Era

Topics

Advertisement
UsernamePublicRestriction

Register

PS069035

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel